Clinical Trials Directory

Trials / Terminated

TerminatedNCT03485794

Collection of Blood in Studying Metabolites in Patients With Prostate Cancer

Metabolic Profiling of Peripheral Blood Mononuclear Cells (PBMCs) by LC-MS in Prostate Cancer Patients

Status
Terminated
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
University of Southern California · Academic / Other
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot research trial utilizes the collection of blood in studying metabolites in patients with prostate cancer. Metabolites are the small molecule products of cellular metabolism that are produced naturally in all living cells. Collecting blood in order to study metabolites may help doctors monitor and treat prostate cancer more effectively.

Detailed description

PRIMARY OBJECTIVES: I. Develop blood sample collection and preparation procedures for reliable, meaningful metabolomic profiling of peripheral blood mononuclear cells (PBMCs) by liquid chromatography/quadruple-time of flight/mass spectrometry (LC/Q-TOF/MS) that can be implemented in a clinical setting. II. Optimize data analysis methods and software usage to create a metabolic profile for patients at the time of blood collection. III. Compare metabolite profiles of isolated PBMCs versus (vs.) other blood fractions (plasma, red blood cells \[RBCs\], and whole blood). IV. Identify elements of the PBMC metabolite profile that may correlate to patient disease state. OUTLINE: Patients undergo collection of blood for metabolic profiling via LC/Q-TOF/MS.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiospecimen CollectionUndergo collection of blood
OTHERLaboratory Biomarker AnalysisCorrelative studies

Timeline

Start date
2017-11-14
Primary completion
2024-01-02
Completion
2024-01-02
First posted
2018-04-02
Last updated
2025-08-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03485794. Inclusion in this directory is not an endorsement.